Comparison of 2 treatment strategies for depressed inpatients: Imipramine and lithium addition or mirtazapine and lithium addition

Journal of Clinical Psychiatry

Volumn 59, Issue 12, 1998, Pages 657-663

  Bruijn, Jan A ^a   Moleman, Peter ^b   Mulder, Paul G H ^c   Van Den Broek, Walter W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Moleman Research   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; IMIPRAMINE; LITHIUM; LORAZEPAM; MIRTAZAPINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIRIUM; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG POTENCY; FEMALE; FEVER; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL;

EID: 0032417362     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v59n1203     Document Type: Article

References (21)

1. Schöpf J. Treatment of depressions resistant to tricyclic antidepressants, related drugs or MAO-inhibitors by lithium addition: review of the literature. Pharmacopsychiatry 1989;22:174-182
2. de Montigny C, Cournoyer C, Morisette R, et al. Lithium-carbonate in tricyclic antidepressant-resistant unipolar depression. Arch Gen Psychiatry 1983;40:1327-1334
3. Heninger GR, Charny DS, Stemberg DE. Lithium carbonate augmentation of antidepressant treatments. Arch Gen Psychiatry 1983;40:1335-1342
4. Kantor D, McNevin S, Leichner P, et al. The benefit of lithium carbonate adjunct in refractory depression - fact or fiction? Can J Psychiatry 1986; 31:416-418
5. Stein G, Bernadt M. Double-blind trial of lithium carbonate in tricyclic resistant depression. In: Birch NJ, ed. Lithium: Inorganic Pharmacology and Psychiatric Use. Oxford, England: Oxford IRL Press; 1988
6. Zusky PM, Biederman J, Rosenbaum JF, et al. Adjunct low dose lithium carbonate in treatment-resistant depression: a placebo-controlled study. J Clin Psychopharmacol 1988;8:120-124
7. Schöpf J, Baumann P, Lemarchand T, et al. Treatment of endogenous depressions resistant to tricyclic antidepressants or related drugs by lithium addition. Pharmacopsychiatry 1989;22:183-187
8. Katona CLE, Abou-Saleh MT, Harrison DA, et al. Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine. Br J Psychiatry 1995;166:80-86
9. Austin MPV, Souza FGM, Goodwin CM. Lithium augmentation in antidepressant-resistant patients: a quantitative analysis. Br J Psychiatry 1991; 159:510-514
10. 2-selective adrenoceptor antagonist ORG 3770 (mirtazapine, Remeron) enhances noradrenergic and serotonergic transmission. Hum Psychopharmacol 1995;10:S107-S118
11. Bruijn JA, Moleman P, Mulder PGH, et al. A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed inpatients. Psychopharmacology 1996;127:231-237
12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987
13. Spitzer RL, Endicott J. Schedule for Affective Disorders and Schizophrenia (SADS), Third Edition. New York, NY: Biometric Research, New York State Psychiatric Institute; 1977
14. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
15. Montgomery SA, Asberg MA. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389
16. Potter WZ, Rudorfer MV. Antidepressants: a comparative review of the clinical pharmacology and the therapeutic use of the "newer" versus the "older" drugs. Drugs 1989;37:713-738
17. Price LH, Conwell Y, Nelson JC. Lithium augmentation of combined neuroleptic-tricyclic treatment in delusional depression. Am J Psychiatry 1983;140:318-322
18. Pai M, White AC, Deane AG. Lithium augmentation in the treatment of delusional depression. Br J Psychiatry 1986;148:736-738
19. Stein G, Bernadt M. Lithium augmentation therapy in tricyclic-resistant depression: a controlled trial using lithium in low and normal doses. Br J Psychiatry 1993;162:634-640
20. Danish University Antidepressant Group. Citalopram: clinical effect profile in comparison with clomipramine: a controlled multicentre study. Psychopharmacology 1986;90:131-138
21. Danish University Antidepressant Group. Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicentre study. J Affect Disord 1990;18:289-299